Catalytic Enantioselective Desymmetrization of meso-Cyclopropane-Fused Cyclohexene-1,4-diones by a Formal C(sp2)–H Alkylation

Sayan Ray; Santanu Mukherjee

doi:10.1055/a-1912-3216

Synlett, Table of Contents

Synlett 2023; 34(07): 863-867
DOI: 10.1055/a-1912-3216

cluster

Chemical Synthesis and Catalysis in India

Catalytic Enantioselective Desymmetrization of meso-Cyclopropane-Fused Cyclohexene-1,4-diones by a Formal C(sp²)–H Alkylation

Sayan Ray

,

Santanu Mukherjee ∗

Abstract

All articles of this category

Abstract

A bicyclo[4.1.0]heptane framework consisting of cis-fused cyclopropane and cyclohexane rings is found in several bioactive compounds. Given the symmetry of this core, catalytic desymmetrization can be considered as the most straightforward strategy for its enantioselective synthesis. Known desymmetrization reactions of meso-bicyclo[4.1.0]heptane derivatives proceed with opening of the cyclopropane ring. We now report the first ring-retentive desymmetrization of bicyclo[4.1.0]heptane derivatives, namely meso-cyclopropane-fused cyclohexene-1,4-diones, through a formal C(sp²)-H alkylation using a nitroalkane as the alkylating agent. This reaction is catalyzed by a dihydroquinine-derived bifunctional tertiary aminosquaramide and generates the products with up to 97:3 er. An application of this reaction is demonstrated by the first catalytic enantioselective synthesis of the natural product (–)-car-3-ene-2,5-dione.

Key words

organocatalysis - desymmetrization - cyclopropanes - bicycloheptanes - fused ring systems

Full Text

References

References and Notes

1a Wiberg KB. Angew. Chem. Int. Ed. Engl. 1986; 25: 312
1b Kozina MP, Mastryukov VS, Mil’vitskaya EM. Russ. Chem. Rev. 1982; 51: 765
1c von Baeyer A. Ber. Dtsch. Chem. Ges. 1885; 18: 2269

2a Ma S, Mandalapu D, Wang S, Zhang Q. Nat. Prod. Rep. 2022; 39: 926
2b Sansinenea E, Ortiz A. Eur. J. Org. Chem. 2022; e202200210
2c Apel C, Christmann M. Tetrahedron 2021; 82: 131760
2d Liu J, Liu R, Wei Y, Shi M. Trends Chem. 2019; 1: 779
2e Novakov IA, Babushkin AS, Yablokov AS, Nawrozkĳ MB, Vostrikova OV, Shejkin DS, Mkrtchyan AS, Balakin KV. Russ. Chem. Bull. 2018; 67: 395
2f Wu W, Lin Z, Jiang H. Org. Biomol. Chem. 2018; 16: 7315
2g Ebner C, Carreira EM. Chem. Rev. 2017; 117: 11651
2h Fan Y.-Y, Gao X.-H, Yue J.-M. Sci. China Chem. 2016; 59: 1126
2i Cavitt MA, Phun LH, France S. Chem. Soc. Rev. 2014; 43: 804
2j Chen DY.-K, Pouwer RH, Richard J.-A. Chem. Soc. Rev. 2012; 41: 4631
2k Tang P, Qin Y. Synthesis 2012; 44: 2969
2l Wessjohann LA, Brandt W, Thiemann T. Chem. Rev. 2003; 103: 1625
2m Gnad F, Reiser O. Chem. Rev. 2003; 103: 1603
2n Lukina MY. Russ. Chem. Rev. 1962; 31: 419
2o Perkin WH. J. Chem. Soc., Trans. 1885; 47: 801
2p Perkin WH. Ber. Dtsch. Chem. Ges. 1884; 17: 323

3 Buzzetti F, Salle E, Lombardi P. DE 3719913 1987
4 Chen Y.-P, Ying S.-S, Zheng H.-H, Liu Y.-T, Wang Z.-P, Zhang H, Deng X, Wu Y.-J, Gao X.-M, Li T.-X, Zhu Y, Xu Y.-T, Wu H.-H. Sci. Rep. 2017; 7: 15114
5 Hashimoto K, Katsuhara T, Itoh H, Ikeya Y, Okada M, Mitsuhashi H. Phytochemistry 1990; 29: 3571

For selected reviews, see:

6a Nájera C, Foubelo F, Sansano JM, Yus M. Tetrahedron 2022; 106–107: 132629
6b Xu Y, Zhai T.-Y, Xu Z, Ye L.-W. Trends Chem. 2022; 4: 191
6c Chegondi R, Patel SM, Maurya S, Donthoju A. Asian J. Org. Chem. 2021; 10: 1267
6d Das T. ChemistrySelect 2020; 5: 14484
6e Borissov A, Davies TQ, Ellis SR, Fleming TA, Richardson MS. W, Dixon DJ. Chem. Soc. Rev. 2016; 45: 5474
6f Zeng X.-P, Cao Z.-Y, Wang Y.-H, Zhou F, Zhou J. Chem. Rev. 2016; 116: 7330
6g Manna MS, Mukherjee S. Org. Biomol. Chem. 2015; 13: 18
6h Fernández-Pérez H, Etayo P, Lao JR, Núñez-Rico JL, Vidal-Ferran A. Chem. Commun. 2013; 49: 10666

7a Pirenne V, Muriel B, Waser J. Chem. Rev. 2021; 121: 227
7b Xia Y, Liu X, Feng X. Angew. Chem. Int. Ed. 2021; 60: 9192

8 Troxler T, Scheffold R. Helv. Chim. Acta 1994; 77: 1193

9a Díaz E, Reyes E, Uria U, Carrillo L, Tejero T, Merino P, Vicario JL. Chem. Eur. J. 2018; 24: 8764
9b Wallbaum J, Garve LK. B, Jones PG, Werz DB. Chem. Eur. J. 2016; 22: 18756
9c Sparr C, Gilmour R. Angew. Chem. Int. Ed. 2011; 50: 8391

10 Müller P, Riegert D. Tetrahedron 2005; 61: 4373

For selected examples of such remote stereocontrol, see:

11a Lou Y, Wei J, Li M, Zhu Y. J. Am. Chem. Soc. 2022; 144: 123
11b Ray S, Mondal S, Mukherjee S. Angew. Chem. Int. Ed. 2022; 61: e202201584
11c Genov GR, Douthwaite JL, Lahdenperä AS. K, Gibson DC, Phipps RJ. Science 2020; 367: 1246
11d Shi H, Herron AN, Shao Y, Shao Q, Yu J.-Q. Nature 2018; 558: 581
11e Su B, Zhou T.-G, Xu P.-L, Shi Z.-J, Hartwig JF. Angew. Chem. Int. Ed. 2017; 56: 7205
11f Sarkar R, Mukherjee S. Org. Lett. 2016; 18: 6160
11g Manna MS, Sarkar R, Mukherjee S. Chem. Eur. J. 2016; 22: 14912
11h Manna MS, Mukherjee S. J. Am. Chem. Soc. 2015; 137: 130
11i Zhou F, Tan C, Tang J, Zhang Y.-Y, Gao W.-M, Wu H.-H, Yu Y.-H, Zhou J. J. Am. Chem. Soc. 2013; 135: 10994
11j Lewis CA, Gustafson JL, Chiu A, Balsells J, Pollard D, Murry J, Reamer RA, Hansen KB, Miller SJ. J. Am. Chem. Soc. 2008; 130: 16358
11k Cefalo DR, Kiely AF, Wuchrer M, Jamieson JY, Schrock RR, Hoveyda AH. J. Am. Chem. Soc. 2001; 123: 3139

12 Mal D, Ray S. Eur. J. Org. Chem. 2008; 2008: 3014
13 For details, see the Supporting Information

For pioneering work on bifunctional thiourea catalysis, see:

14a Okino T, Hoashi Y, Takemoto Y. J. Am. Chem. Soc. 2003; 125: 12672. For seminal works on cinchonaalkaloid-based bifunctional thiourea catalysts, see
14b Li B.-J, Jiang L, Liu M, Chen Y.-C, Ding L.-S, Wu Y. Synlett 2005; 603
14c McCooey SH, Connon SJ. Angew. Chem. Int. Ed. 2005; 44: 6367
14d Vakulya B, Varga S, Csámpai A, Soós T. Org. Lett. 2005; 7: 1967
14e Ye J, Dixon DJ, Hynes PS. Chem. Commun. 2005; 4481

15 For seminal work on bifunctional squaramide catalysts, see: Malerich JP, Hagihara K, Rawal VH. J. Am. Chem. Soc. 2008; 130: 14416
16 Odriozola A, Oiarbide M, Palomo C. Chem. Eur. J. 2017; 23: 12758

Catalytic Enantioselective Alkylative Desymmetrization of meso-Cyclopropane-Fused Cyclohexene-1,4-Diones; General ProcedureA glass vial was charged with freshly activated 5 Å MS (150 mg), catalyst III (0.06 mmol, 0.2 equiv), Na₂CO₃ (0.45 mmol, 1.5 equiv), and the appropriate cyclopropane-fused enedione 10 (0.30 mmol, 1.0 equiv) under a positive argon pressure. Distilled CHCl₃ (3.0 mL) was added and the resulting suspension was stirred at 25 °C for 10 min. Nitroalkane 11 (11b or 11c: 3.0 mmol; 11c–f: 1.5 mmol) was then added, and the resulting mixture was stirred at 25 °C until complete conversion of 10 (TLC). The mixture was then diluted with CH₂Cl₂ (2 mL) and filtered through Celite, which was washed with additional CH₂Cl₂ (3 × 5 mL). The combined organic phase was concentrated under reduced pressure and the residue was purified by flash column chromatography (silica gel).(1R,6S)-3-Methylbicyclo[4.1.0]hept-3-ene-2,5-dione (12aa)Prepared according to the general procedure, and purified by flash column chromatography (silica gel, 20–25% EtOAc–PE) to give a thick yellow oil; yield: 36 mg (0.264 mmol, 88%); [α]_D ²² –83.7 (c 1.0, CHCl₃) for an enantiomerically enriched sample with 92:8 er. HPLC [Daicel Chiralpak IG, hexane–EtOH (60:40), 1.0 mL/min, 20 °C, λ = 254 nm]: t _minor = 14.7 min, t _major = 17.5 min. FTIR (thin film): 3340 , 3062 , 2924 , 1726 , 1674 , 1620 , 1440 , 1348 , 1282 cm^–1. ¹H NMR (400 MHz, CDCl₃): δ = 6.29 (s, 1 H), 2.55–2.46 (m, 2 H), 1.95 (s, 3 H), 1.67 (dt, J ₁ = 8.7, J ₂ = 4.9 Hz, 1 H), 1.58 (q, J = 5.1 Hz, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 195.7, 194.8, 146.4, 133.7, 27.8, 27.0, 20.1, 16.5. HRMS (APCI): m/z [M + H]⁺ calcd for C₈H₉O₂: 137.0603; found: 137.0605. (1R,6S)-3-Benzylbicyclo[4.1.0]hept-3-ene-2,5-dione (12ac)Prepared according to the general procedure and purified by flash column chromatography (silica gel, 12–15% EtOAc–PE) as a yellow oil; yield: 33 mg (0.155 mmol, 52%); [α]_D ²² –43.3 (c 2.0, CHCl₃) for an enantiomerically enriched sample with 79:21 er.HPLC [Daicel Chiralpak IG, hexane–EtOH (60:40), 1.0 mL/min, 20 °C, λ = 254 nm]: t _minor = 10.9 min, t _major = 27.5 min. FTIR (thin film): 3061 , 3028 , 2924 , 1675 , 1614 , 1495 , 1346 , 1279 , 1041 , 700 cm^–1. ¹H NMR (400 MHz, CDCl₃): δ = 7.26–7.22 (m, 2 H), 7.20–7.18 (m, 1 H), 7.07 (d, J = 7.1 Hz, 2 H), 6.00 (br m, 1 H), 3.57 (dd, J ₁ = 29.6, J ₂ = 16.2 Hz, 2 H), 2.50–2.40 (m, 2 H), 1.61–1.55 (m, 1 H), 1.47 (q, J = 5.0 Hz, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 195.1, 194.9, 149.2, 136.5, 133.3, 129.3, 129.0, 127.1, 35.8, 27.9, 27.2, 19.9. HRMS (ESI+): m/z [M + H]⁺ calcd for C₁₄H₁₃O₂: 213.0916; found: 213.0918.(–)-Car-3-ene-2,5-dione (12ca)Prepared according to the general procedure and purified by flash column chromatography (silica gel, 15–17% EtOAc–PE) as a yellow crystalline solid; yield: 31 mg (0.183 mmol, 61%); mp 77–79 °C; [α]_D ²² –13.9 (c 0.25, CHCl₃) for an enantiomerically enriched sample with 94.5:5.5 er.HPLC [Daicel Chiralpak IG, hexane–EtOH (60:40), 1.0 mL/min, 20 °C, λ = 254 nm]: t _minor = 9.4 min, t _major = 17.3 min. FTIR (thin film): 3034 , 2962 , 1662 , 1447 , 1370 , 1289 , 1125 cm^–1. ¹H NMR (400 MHz, CDCl₃): δ = 6.50–6.49 (br m, 1 H), 2.35–2.30 (m, 2 H), 1.97 (d, J = 1.3 Hz, 3 H), 1.32 (s, 3 H), 1.31 (s, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 195.1, 194.5, 150.1, 137.8, 40.0, 39.1, 33.7, 29.2, 16.3, 15.6. HRMS (ESI+): m/z [M + H]⁺ calcd for C₁₀H₁₃O₂: 165.0916; found: 165.0918.

18 Galin FZ, Kashina YA, Zainullin RA, Kukovinets OS, Khalilov LM, Tolstikov GA. Russ. Chem. Bull. 1998; 47: 185
19 Gomes SQ, Salles AG. Jr. Synth. Commun. 2019; 49: 3389

Supplementary Material

Supporting Information